Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

1. Hernando Cubero, J.
2. Grande, E.
3. Jimenez Fonseca, P.
4. Villabona, C.
5. Trigo Perez, J.M.
6. Martinez Trufero, J.
7. Pajares Bernad, I.
8. Lopez, C.
9. Alonso, T.
10. Biarnes, J.
11. RamónY Cajal, T.
12. Duran, M.
13. Grau, J.J.
14. Arevalo Lobera, S.
15. Mesia Nin, R.
16. Llanos, M.
17. Dalmau Portulas, E.
18. Alvarez, C.
19. Zafon, C.
20. Capdevila, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDY293.022 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus